David Carroll
Nessuna posizione attualmente
Profilo
David F.
Carroll worked as the Chief Accounting Officer & Senior Vice President at The Medicines Co. from 2008 to 2016.
He also worked as the Chief Financial Officer, Treasurer & Senior VP at IVERIC bio, Inc. Mr. Carroll holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Ursinus College.
Precedenti posizioni note di David Carroll
| Società | Posizione | Fine |
|---|---|---|
| THE MEDICINES COMPANY | Comptroller/Controller/Auditor | 01/06/2016 |
| IVERIC BIO, INC. | Director of Finance/CFO | - |
Formazione di David Carroll
| Rutgers State University of New Jersey | Masters Business Admin |
| Ursinus College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Borsa valori
- Insiders
- David Carroll
